|Scientific Subdivisions | The Journal of Molecular Diagnostics
Contact AMP | Sign In | Join / Renew | Go To CHAMP
AMP 2014 Annual Meeting
AMP CELEBRATES 20 YEARS!
November 13 -15, 2014
Corporate Workshop Day & Gala, November 12, 2014
Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)
Click for a complete listing of AMP guidelines and reports.
AMP Clinical Practice Guidelines and Reports are developed to be of assistance to laboratory and other health care professionals by providing guidance and recommendations for particular areas of practice. The Guidelines or Report should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines or Report cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines or Report are not intended to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances.
AMP makes no warranty, express or implied, regarding the Guidelines or Report and specifically excludes any warranties of merchantability and fitness for a particular use or purpose. AMP shall not be liable for direct, indirect, special, incidental, or consequential damages related to the use of the information contained herein.
Molecular Markers for Colorectal Cancer
Being developed jointly by the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP),and the Association for Molecular Pathology (AMP).
Laboratory Practice Guidelines for Detecting and Reporting JAK2 and MPL Mutations in Myeloproliferative Neoplasms: A Report of the Association for Molecular Pathology. Published in the November 2013 issue of the Journal of Molecular Diagnostics.
The Role of MGMT Testing in Clinical Practice: A Report of the Association for Molecular Pathology. Published in the September 2013 issue of the Journal of Molecular Diagnostics.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors (April 2013). Developed jointly by the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP). Click here for more information...
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing: A Report of the Association for Molecular Pathology. Published in the November 2012 issue of the Journal of Molecular Diagnostics.
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair-Defective Colorectal Carcinomas: A Report of the Association for Molecular Pathology.
Published in the March 2012 issue of the Journal of Molecular Diagnostics.
For a complete list of AMP guidelines and reports, see the "Index of Practice Guidelines" spreadsheet on the upper right menu box of this webpage.